Detroit hospital treats first high-risk patient with Tryton stent
St. John Hospital & Medical Center became the first facility in the United States to treat a high-risk patient with a heart pump and newly approved Tryton Side Branch Stent, according to a June 2 release.
Antonious Attallah, MD, a cardiologist at St. John’s in Detroit, performed the groundbreaking procedure, which included the new stent and an Impella heart pump.
"Stenosis, or narrowing, located in a main coronary artery and an adjoining side-branch vessel is called a bifurcation blockage or bifurcation lesion," Attallah said. "Bifurcation blockages are somewhat more challenging for cardiac interventionalists to treat than blockages that do not involve side-branch vessels, because current stents do not come in a ‘Y’ configuration."
The Tryton stent is designed to provide complete lesion coverage, deployed in the side branch artery using a standard wire balloon-expandable delivery system, with a drug eluting stent place in the main vessel.